News

Cambrex Corporation announced that it has completed an expansion of cGMP small scale capacity at its Charles City, Iowa plant. The project has seen the installation of two 500…
Read More...

RxCelerate announced it has hired Laura Hamilton as Executive Vice President, U.S. Operations and opened an office in Cambridge, Massachusetts, just outside Boston. "We are bringing…
Read More...

Boehringer Ingelheim and MiNA Therapeutics (“MiNA”) announced that they have signed a collaboration and licensing agreement focused on the development of novel compounds to treat…
Read More...

Neurimmune announced that it has entered into a collaboration with Ono Pharmaceutical Co., Ltd. focused on the development of human antibodies against a novel therapeutic target for…
Read More...

Valeant Pharmaceuticals International announced that its affiliate has entered into an agreement to divest the Sprout Pharmaceuticals subsidiary ("Sprout") to a buyer affiliated with…
Read More...

In a small safety trial based on preclinical work by a Stanford researcher, participants receiving blood plasma infusions from young donors showed some evidence of improvement.…
Read More...

Spanish pharmaceutical company Almirall opted for Werum’s PAS-X Manufacturing Execution System to be installed in the German plant in Reinbek near Hamburg. Almirall is the market leader…
Read More...

The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare…
Read More...

Millendo Therapeutics announced positive topline results from a Phase 2 proof-of-concept study of ATR-101 in classic congenital adrenal hyperplasia (CAH), a rare inherited endocrine…
Read More...

Torrent Pharmaceuticals Limited and Unichem Laboratories Limited announced that Torrent has entered into a definitive binding agreement with Unichem to acquire its branded business of…
Read More...

PharmaMar has announced a licensing agreement with Boryung Pharm to commercialize the marine-derived anticancer drug Zepsyre (lurbinectedin), if approved, in South Korea. Under the…
Read More...

TherapeuticsMD announced a regulatory update regarding the New Drug Application (NDA) for TX-004HR, the Company’s investigational applicator-free estradiol vaginal softgel capsule for…
Read More...

FUJIFILM Corporation is to invest a total of 3.2 billion yen on its CDMO sites in the U.S.A. and the U.K. in order to accelerate the expansion of the company's business for developing…
Read More...

Abbott announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved the company's MitraClip device for treatment of people with mitral regurgitation (MR), a…
Read More...

Artemis Therapeutics announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation for Artemisone, the Company's lead product candidate, for the treatment…
Read More...

Janssen Research & Development, LLC (Janssen) announced positive results from a randomized, placebo-controlled Phase 2 study investigating the anti-interleukin (IL)-12/23 monoclonal…
Read More...

Stealth BioTherapeutics (Stealth) announced the initiation of MMPOWER-3, a Phase 3 study evaluating the efficacy and safety of daily subcutaneous injections of elamipretide in patients…
Read More...

Boehringer Ingelheim and Dicerna Pharmaceuticals announced a research collaboration and license agreement to discover and develop novel GalXC™ RNAi therapeutics for the treatment of…
Read More...

The Canadian scientific community gathered in Ottawa this week to engage in a national dialogue on science, technology and innovation policy at the annual Canadian Science Policy…
Read More...

Otsuka Pharmaceutical announced detailed results from the Phase 3 REPRISE trial of tolvaptan in patients with autosomal dominant polycystic kidney disease (ADPKD). Trial results…
Read More...